Clinical Trials Directory

Trials / Completed

CompletedNCT04195932

Exercise as a Modulator of Immune Risk Factors for Ischemic Heart Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
East Tennessee State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A before and after study involving 43 adult subjects at risk of having ischemic heart disease. Subjects underwent 6 months of supervised moderate intensity aerobic and resistive exercise training. Blood samples were obtained at entry and at 6 months for measurement of complement (C3), CRP, blood lipid levels, lymphocyte phenotypes, and for the isolation, culture, and measurement of the spontaneous and phytohemagglutinin-induced secretion of proatherogenic and antiatherogenic cytokines by their peripheral blood mononuclear cells (PBMC).

Detailed description

A before and after study involving 43 adult subjects at risk of having ischemic heart disease. Subjects underwent 6 months of supervised moderate intensity aerobic and resistive exercise training. Blood samples were obtained at entry and at 6 months for measurement of complement (C3), CRP, blood lipid levels, lymphocyte phenotypes, and for the isolation, culture, and measurement of the spontaneous and phytohemagglutinin-induced secretion of proatherogenic and antiatherogenic cytokines by their peripheral blood mononuclear cells (PBMC

Conditions

Interventions

TypeNameDescription
OTHERExercise training

Timeline

Start date
1996-12-01
Primary completion
1998-05-01
Completion
1998-05-01
First posted
2019-12-12
Last updated
2019-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04195932. Inclusion in this directory is not an endorsement.